SonoScape Flagship 4-LED equipped FHD Endoscopy System

Demostrated at Conference "Endoscopy on Air"

SonoScape notes on June 5, 2020, “Endoscopy on Air”, an on-line international GI endoscopy conference led by faculties from 23 cities worldwide has attracted more than 20,000 viewers. The event touched upon the full spectrum of diagnostic and therapeutic endoscopy through the live streaming of more than 50 cases. SonoScape participated in the event as the silver sponsor.

SonoScape started as one of the top ultrasound manufacturers globally, but it refused to be limited by its own shadow. Since the establishment of its endoscopy division in 2012, the company keeps up its incredibly fast pace in product development. The latest and much-praised HD-550, a Full-High-Definition video endoscopy system is now paired with a 4-LED light source, setting up a major milestone on SonoScape’s product roadmap. The system delivers a noticeably boosted performance. At every turn, the added brightness allows even more image details, under both White Light or chromoendoscopy SFI/VIST modes.

The new SonoScape Flagship 4-LED equipped FHD Endoscopy System was used in two live demos of the marathonlike endoscopy Live conference. Cases were performed respectively by Prof. Zhou Ping-Hong, a global elite doctor in Shanghai Zhongshan Hospital of Fudan University in China, and Dr. Roberta Maselli in Humanitas Hospital Milan, Italy.

“This is one of the best endoscopic images I have ever seen.” Dr. Maselli commented during her procedure: “Plus, the aspect of extensive vascular ectasias in the stomach is clearly revealed, as it becomes much more noticeable under the SFI mode.”

Facing a transformational time for industry conferences, SonoScape’s new flagship system, HD-550 with 4-LED light source, received high appraisals from the endoscopist community, both online and off.

SourceSonoScape
Medical Device News Magazinehttps://infomeddnews.com
Our publication is dedicated to bringing our readers the latest medical device news. We are proud to boast that our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall purpose and objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

Clozapine has been established as the most effective antipsychotic medication for treatment-resistant schizophrenia. However, it is significantly underutilized mainly due to the risk of developing agranulocytosis and the need to frequently monitor the absolute neutrophil count (ANC).
Dagi-Ben Noon, CEO of Inspira Technologies, reflects on the partnership's significance: "By Integrating our technology to oxygenate blood directly with Ennocure's infection prevention solutions, we are focusing on potentially improving patient outcomes in ICUs and paving the way for safer, more effective life-support treatments. This collaboration is expected to accelerate the development and broaden the implementation of our advanced technology."
The findings suggest that the novel, non-invasive genomic test can help physicians guide next steps for these patients, enabling them to potentially avoid unnecessary invasive procedures or accelerate time to appropriate treatment.
“These study results are highly encouraging especially given the short treatment duration of 10 days with BX004,” said Jonathan Solomon, Chief Executive Officer of BiomX. “In Part 2 of the study, BX004 showed clinically meaningful improvement in pulmonary function compared to placebo, as measured by relative FEV11 improvement (5.67% at Day 17, 1 week after end of treatment) and Cystic Fibrosis Questionnaire-Revised (CFQ-R) respiratory domain (8.87 points at Day 17) in a predefined subgroup of patients with reduced lung function.”  
Importantly, the study reported no serious treatment-related adverse events from any of the 109 patients treated with InGeneron’s Transpose® RT cell therapy system.

By using this website you agree to accept Medical Device News Magazine Privacy Policy